Genesis Therapeutics

Genesis Therapeutics harnesses generative AI and physics-based research to revolutionize drug discovery. Its proprietary GEMS platform targets complex protein structures, designing highly potent and selective drug candidates at speed. The company addresses challenging therapeutic areas by integrating interdisciplinary expertise in AI and biotechnology, bringing new hope to patients. It is advancing a pipeline of groundbreaking medicines that redefine what’s possible in precision medicine and chemical innovation.